Moorfields hospital in London is the world's first dedicated clinic for the disorder and seven out of eight patients given ...
The first-ever patient to receive groundbreaking eye injection treatment broke her silence after regaining her ...
The FDA has approved Zycubo (copper histidinate) injection as the first and only treatment of Menkes disease in pediatric ...
Lunsumio VELO, a subcutaneous CD20xCD3 bispecific antibody, is approved for relapsed or refractory follicular lymphoma after two systemic therapies. The GO29781 study reported a 75% objective response ...
Geographic atrophy (GA) is a chronic, progressive degeneration of the macula that can occur in some people with dry macular degeneration. GA is a late, or advanced, stage of the disease. The people ...
A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment runs $20,000. He’s now working to bring the unproven treatment to the US.
Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback